Weighing daily and looking at monthly trends often provides more clarity than weekly weigh-ins, which may fall during the luteal phase and create false impressions of stalling
And some people may simply not respond well to GLP-1s without any obvious cause
2,3 Against this backdrop, oral GLP-1 receptor agonists are emerging as an increasingly important area of focus, as companies look to extend growth beyond injectables and broaden access to obesity care
Theres no longer any guidelines that say we have to take women off MHT, so they can be on it forever if they have a reason to.
GLP-1 medications are relatively new, so long-term risks have not been seen at this time
Leaving a vial out on the lab bench overnight could render it significantly less potent, if not entirely inert, by morning